Carter's Inc. (CRI) Stock Forecast
Data as of Oct 31, 2026Consumer Cyclical · Current price $31.16 (-6.65%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 28, 2025 | Paul Kearney | Barclays | $25.00 | -19.8% |
| Jul 26, 2024 | Warren Cheng | Evercore ISI | $60.00 | +92.6% |
| Apr 26, 2024 | Zachary Warring | CFRA | $84.00 | +169.6% |
Top Analysts Covering CRI
CRI vs Sector & Market
| Metric | CRI | Consumer Cyclical Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 3.00 | 2.47 | 2.41 |
| Analyst Count | 4 | 12 | 19 |
| Target Upside | +28.4% | +248.0% | +21.5% |
| P/E Ratio | 10.93 | 16.44 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2027-01-03 | $933M | $940M | $945M | 1 |
| 2027-04-03 | $652M | $657M | $661M | 1 |
| 2027-07-03 | $597M | $601M | $604M | 1 |
| 2027-10-03 | $792M | $797M | $802M | 1 |
| 2028-01-03 | $946M | $953M | $958M | 1 |
| 2029-01-03 | $3.06B | $3.06B | $3.06B | 4 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2027-01-03 | $2.19 | $2.21 | $2.23 | 1 |
| 2027-04-03 | $0.22 | $0.22 | $0.22 | 1 |
| 2027-07-03 | $-0.11 | $-0.11 | $-0.11 | 1 |
| 2027-10-03 | $1.04 | $1.05 | $1.06 | 1 |
| 2028-01-03 | $2.24 | $2.26 | $2.28 | 1 |
| 2029-01-03 | $3.85 | $3.88 | $3.91 | 1 |
Frequently Asked Questions
What is the analyst consensus for CRI?
The consensus among 4 analysts covering Carter's Inc. (CRI) is Hold with an average price target of $40.75.
What is the highest price target for CRI?
The highest price target for CRI is $84.00, set by Zachary Warring at CFRA on 2024-04-26.
What is the lowest price target for CRI?
The lowest price target for CRI is $25.00, set by Paul Kearney at Barclays on 2025-04-28.
How many analysts cover CRI?
4 analysts have issued ratings for Carter's Inc. in the past 12 months.
Is CRI a buy or sell right now?
Based on 4 analyst ratings, CRI has a consensus rating of Hold (3.00/5) with a +28.4% upside to the consensus target of $40.75.
What are the earnings estimates for CRI?
Analysts estimate CRI will report EPS of $2.21 for the period ending 2027-01-03, with revenue estimated at $940M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.